BioMarin Pharma (NASDAQ: BMRN) announced that the Peripheral and Central Nervous System Drugs Advisory Committee of the U.S. Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE